MAPK3 and lung carcinoma: These results were also supported by previous studies [24,25,40], in which silibinin attenuated cigarette smoke-induced pulmonary inflammation by suppressing ERK1/2 and downregulated the expression of MAPK and AP-1 in human lung carcinoma cells.